About: Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7588/w
Subject	Practice Drugs: cardiovascular system Patients General practice / family medicine Heart failure Medicines regulation Stroke Fluid electrolyte and acid-base disturbances Medical error/ patient safety Drugs: musculoskeletal and joint diseases Hypertension Arrhythmias
Title	Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin
has manifestation of work	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7588/B36E2D0DEBC42B90E053120B220A9D4F/m/print http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7588/B36E2D0DEBC42B90E053120B220A9D4F/m/web
related by	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7588/B36E2D0DEBC42B90E053120B220A9D4F/authorship/1 http://hub.abes.fr/bmj/periodical/bmj/2007/volume_334/issue_7588/B36E2D0DEBC42B90E053120B220A9D4F/authorship/2
Abstract	Patients on a range of drug therapies are often not monitored appropriately, even though this can improve patient safety. Knowledge of the effects of drugs on non-target body systems is essential to guide monitoring and interpretation of monitoring tests
article type	research-article
publisher identifier	smew443648
is part of this journal	British Medical Journal
PubMed ID	17289735

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata